Adeno-associated virus serotypes: vector toolkit for human gene therapy
Ofev (nintedanib) Disease area(s): Respiratory Manufacturer(s): Boehringer Ingelheim 2024 Sales (USD): $4.07 billion Why it sold so well: In 2024, Boehringer Ingelheims Ofev achieved significant commercial success, with global sales reaching 3.77 billion ($4.07 billion), marking a 7.3% increase at constant exchange rates compared to the previous year
Health Risks Linked to Hyperlipidemia When blood fat levels are too high, they can build up inside the arteries
Status of novel drug delivery technology for phytotherapeutics
That said, BPC-157 has not shown organ toxicity, hormonal disruption, or carcinogenic potential in available models
These are often mild and temporary as your body adjusts to the treatment